共 39 条
Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells
被引:16
作者:
Sun, Michael
[1
]
Ha, Ngoc
[1
,2
]
Pham, Duc-Hung
[1
,3
]
Frederick, Megan
[4
]
Sharma, Bandana
[5
,6
]
Naruse, Chie
[7
]
Asano, Masahide
[7
]
Pipkin, Matthew E.
[4
]
George, Rani E.
[5
,6
,8
]
Thai, To-Ha
[1
]
机构:
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[2] Drexel Univ, Dept Neurobiol & Anat, Coll Med, 2900 Queen Lane, Philadelphia, PA 19129 USA
[3] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA
[4] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA
[5] Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02215 USA
[6] Boston Childrens Hosp, Boston, MA 02215 USA
[7] Kyoto Univ, Inst Lab Anim, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan
[8] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA
来源:
关键词:
ANTI-GD2;
MONOCLONAL-ANTIBODY;
HETEROCHROMATIN PROTEIN-1;
TRANSCRIPTION ELONGATION;
NKG2D;
HP1-GAMMA;
METHYLATION;
THERAPY;
HP1;
MECHANISMS;
EXHAUSTION;
D O I:
10.1038/srep42888
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Cbx3/HP1 gamma is a histone reader whose function in the immune system is not completely understood. Here, we demonstrate that in CD8(+) T cells, Cbx3/HP1. insufficiency leads to chromatin remodeling accompanied by enhanced Prf1, Gzmb and Ifng expression. In tumors obtained from Cbx3/HP1 gamma-insufficient mice or wild type mice treated with Cbx3/HP1 gamma-insufficient CD8(+) T cells, there is an increase of CD8(+) effector T cells expressing the stimulatory receptor Klrk1/NKG2D, a decrease in CD4(+) CD25(+) FOXP3(+) regulatory T cells (Treg cells) as well as CD25(+) CD4(+) T cells expressing the inhibitory receptor CTLA4. Together these changes in the tumor immune environment may have mitigated tumor burden in Cbx3/HP1 gamma-insufficient mice or wild type mice treated with Cbx3/HP1 gamma-insufficient CD8(+) T cells. These findings suggest that targeting Cbx3/HP1. can represent a rational therapeutic approach to control growth of solid tumors.
引用
收藏
页数:12
相关论文